

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.38698750 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.90226392 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.64783283 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61874610 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.61874610 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27137806 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.27137806 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.84348462 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.37191424 |
| 10 | oxidative demethylation (GO:0070989) | 6.16968978 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.14697338 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.14697338 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.14697338 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.03009422 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.99045059 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.79698894 |
| 17 | urea metabolic process (GO:0019627) | 5.75879900 |
| 18 | urea cycle (GO:0000050) | 5.75879900 |
| 19 | drug metabolic process (GO:0017144) | 5.75248344 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.73216704 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.71527647 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.59776900 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54733245 |
| 24 | cysteine metabolic process (GO:0006534) | 5.41763625 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.37926111 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.37125903 |
| 27 | protein carboxylation (GO:0018214) | 5.34343388 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.34343388 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.33170758 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.29459922 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.29403384 |
| 32 | S-adenosylmethionine metabolic process (GO:0046500) | 5.26290989 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.15758309 |
| 34 | bile acid metabolic process (GO:0008206) | 5.13999802 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.97003372 |
| 36 | regulation of complement activation (GO:0030449) | 4.92783027 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92512315 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.89160389 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.87810347 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.86957764 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.84646539 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.84592101 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.79093630 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.79093630 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79093630 |
| 46 | ethanol metabolic process (GO:0006067) | 4.73492530 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.70497145 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.69095135 |
| 49 | lysine catabolic process (GO:0006554) | 4.63582783 |
| 50 | lysine metabolic process (GO:0006553) | 4.63582783 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.61390408 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.61390408 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.58910172 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.58910172 |
| 55 | phospholipid efflux (GO:0033700) | 4.56838746 |
| 56 | phenylpropanoid metabolic process (GO:0009698) | 4.55634515 |
| 57 | glycine metabolic process (GO:0006544) | 4.46069909 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.43789635 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.42876486 |
| 60 | alkaloid metabolic process (GO:0009820) | 4.37620202 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.36548136 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.35671182 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.34819209 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.33593405 |
| 65 | cellular glucuronidation (GO:0052695) | 4.33389325 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 4.31587295 |
| 67 | glutamate metabolic process (GO:0006536) | 4.27783995 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.26315854 |
| 69 | amine catabolic process (GO:0009310) | 4.26315854 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 4.23457355 |
| 71 | cholesterol efflux (GO:0033344) | 4.21479203 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 4.13217352 |
| 73 | serine family amino acid biosynthetic process (GO:0009070) | 4.08485968 |
| 74 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08466046 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08306773 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 4.07637581 |
| 77 | ethanol oxidation (GO:0006069) | 4.06639422 |
| 78 | arginine metabolic process (GO:0006525) | 4.04056886 |
| 79 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.01032383 |
| 80 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.01032383 |
| 81 | drug catabolic process (GO:0042737) | 4.00367622 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 3.98838544 |
| 83 | aldehyde catabolic process (GO:0046185) | 3.97953349 |
| 84 | fibrinolysis (GO:0042730) | 3.97445336 |
| 85 | ketone body metabolic process (GO:1902224) | 3.84239498 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.83598586 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.83598586 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82895145 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.78859293 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78263088 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78263088 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.77978237 |
| 93 | organic acid catabolic process (GO:0016054) | 3.77978237 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77244079 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76491181 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.75928810 |
| 97 | cofactor catabolic process (GO:0051187) | 3.75902927 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.74935134 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.74007946 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.72195787 |
| 101 | complement activation (GO:0006956) | 3.70816316 |
| 102 | acetyl-CoA metabolic process (GO:0006084) | 3.69834200 |
| 103 | protein activation cascade (GO:0072376) | 3.69776734 |
| 104 | behavioral response to nicotine (GO:0035095) | 3.69776139 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.68549779 |
| 106 | sterol homeostasis (GO:0055092) | 3.67855348 |
| 107 | sodium-independent organic anion transport (GO:0043252) | 3.67656244 |
| 108 | regulation of plasminogen activation (GO:0010755) | 3.65769690 |
| 109 | plasma lipoprotein particle organization (GO:0071827) | 3.62538709 |
| 110 | amino acid salvage (GO:0043102) | 3.62531490 |
| 111 | L-methionine salvage (GO:0071267) | 3.62531490 |
| 112 | L-methionine biosynthetic process (GO:0071265) | 3.62531490 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.61015069 |
| 114 | cytolysis (GO:0019835) | 3.59557894 |
| 115 | negative regulation of protein activation cascade (GO:2000258) | 3.59252816 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.56992305 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.56801102 |
| 118 | opsonization (GO:0008228) | 3.52476237 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 3.50311473 |
| 120 | heme transport (GO:0015886) | 3.50131036 |
| 121 | negative regulation of hemostasis (GO:1900047) | 3.47871064 |
| 122 | negative regulation of blood coagulation (GO:0030195) | 3.47871064 |
| 123 | xenobiotic metabolic process (GO:0006805) | 3.47329772 |
| 124 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40217707 |
| 125 | regulation of humoral immune response (GO:0002920) | 3.37021687 |
| 126 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.33006381 |
| 127 | negative regulation of coagulation (GO:0050819) | 3.25538998 |
| 128 | acute-phase response (GO:0006953) | 3.23856769 |
| 129 | xenobiotic catabolic process (GO:0042178) | 3.21415989 |
| 130 | negative regulation of wound healing (GO:0061045) | 3.12944019 |
| 131 | drug transmembrane transport (GO:0006855) | 3.08817444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46645856 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21906350 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07655153 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53680239 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32975137 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17872530 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88120640 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.08229042 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01486043 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.99948043 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.81789548 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.62571186 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.45164307 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.34420773 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29809526 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16928525 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10051766 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00321023 |
| 19 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9724237 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98279014 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94300321 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85919488 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82121603 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80952679 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70073662 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68588011 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67805192 |
| 28 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.61064878 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.60855360 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60526198 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58500093 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58090943 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54893881 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53559191 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50584825 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.48335085 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43322549 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43136039 |
| 39 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.41387257 |
| 40 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41252116 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41252116 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40310248 |
| 43 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.39442320 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38291400 |
| 45 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35409899 |
| 46 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35409899 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35239007 |
| 48 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33337688 |
| 49 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31988376 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31988376 |
| 51 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29696448 |
| 52 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.29533145 |
| 53 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28565318 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.27159845 |
| 55 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27111833 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25632261 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25445677 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25334779 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25310233 |
| 60 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.25141833 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24796460 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24390921 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23552679 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22712720 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21843172 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20032468 |
| 67 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19396864 |
| 68 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19060750 |
| 69 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18549476 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18063847 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16490036 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16024031 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12292428 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12262034 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11102018 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10380615 |
| 77 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09498527 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08924598 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07809068 |
| 80 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07589909 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07447370 |
| 82 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.05956294 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05882932 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04652673 |
| 85 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04401703 |
| 86 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03077686 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02622844 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02553203 |
| 89 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02378101 |
| 90 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99014775 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98952234 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98844025 |
| 93 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98755761 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97847223 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97702262 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97316372 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97006541 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96934864 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96934864 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95540668 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92444076 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91689600 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85470382 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85329098 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83192945 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81246037 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80938249 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79103086 |
| 109 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78825610 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78808483 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77227398 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75903179 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73669834 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72950233 |
| 115 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72438345 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71270805 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69737211 |
| 118 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69480316 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68028239 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65584836 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64479565 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64479565 |
| 123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62142002 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61375530 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60532432 |
| 126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.59923277 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59271127 |
| 128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58818125 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58138292 |
| 130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57674819 |
| 131 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57570832 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53703273 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53519727 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52835120 |
| 135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52538699 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52521521 |
| 137 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51066086 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49780251 |
| 139 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.49714554 |
| 140 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49543616 |
| 141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49473345 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48459665 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47916120 |
| 144 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47849856 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47242602 |
| 146 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46933622 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45234883 |
| 148 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43682700 |
| 149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43444842 |
| 150 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43221594 |
| 151 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41494797 |
| 152 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41213951 |
| 153 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40577261 |
| 154 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40214897 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40196134 |
| 156 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40032616 |
| 157 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.39191041 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39149480 |
| 159 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38650012 |
| 160 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38471276 |
| 161 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38442357 |
| 162 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.38173835 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38055510 |
| 164 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37880197 |
| 165 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37678149 |
| 166 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36841875 |
| 167 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36567189 |
| 168 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36414295 |
| 169 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35637815 |
| 170 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34310082 |
| 171 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34114906 |
| 172 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33781762 |
| 173 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33676370 |
| 174 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33329636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.35740367 |
| 2 | MP0005360_urolithiasis | 7.48529890 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.50797093 |
| 4 | MP0005365_abnormal_bile_salt | 6.24300702 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.24444060 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.29355267 |
| 7 | MP0003252_abnormal_bile_duct | 3.94998580 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58801721 |
| 9 | MP0009840_abnormal_foam_cell | 3.27045061 |
| 10 | MP0005083_abnormal_biliary_tract | 3.08764469 |
| 11 | MP0005332_abnormal_amino_acid | 2.78555203 |
| 12 | MP0003195_calcinosis | 2.75970886 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60514214 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.27929382 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17631235 |
| 16 | * MP0002118_abnormal_lipid_homeostasis | 2.08310849 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.01452309 |
| 18 | MP0003868_abnormal_feces_composition | 1.96992016 |
| 19 | * MP0004019_abnormal_vitamin_homeostasis | 1.88192299 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83936105 |
| 21 | MP0001764_abnormal_homeostasis | 1.67646087 |
| 22 | MP0009697_abnormal_copulation | 1.64657851 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57869605 |
| 24 | * MP0005551_abnormal_eye_electrophysiolog | 1.53930303 |
| 25 | MP0005451_abnormal_body_composition | 1.50649902 |
| 26 | MP0004043_abnormal_pH_regulation | 1.46167324 |
| 27 | MP0003011_delayed_dark_adaptation | 1.40549245 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.31219469 |
| 29 | MP0003186_abnormal_redox_activity | 1.29875055 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.23451995 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.22402050 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.20451628 |
| 33 | MP0002102_abnormal_ear_morphology | 1.19585819 |
| 34 | MP0000598_abnormal_liver_morphology | 1.18813006 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.18045121 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.14843360 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.14333812 |
| 38 | MP0005647_abnormal_sex_gland | 1.13482259 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.10670064 |
| 40 | MP0009745_abnormal_behavioral_response | 1.10417676 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.07319310 |
| 42 | MP0000604_amyloidosis | 1.06573453 |
| 43 | MP0004885_abnormal_endolymph | 1.05950770 |
| 44 | MP0009764_decreased_sensitivity_to | 1.05774065 |
| 45 | MP0002254_reproductive_system_inflammat | 1.04809548 |
| 46 | MP0009763_increased_sensitivity_to | 1.03033124 |
| 47 | MP0003136_yellow_coat_color | 0.98980527 |
| 48 | * MP0004142_abnormal_muscle_tone | 0.97571638 |
| 49 | MP0003646_muscle_fatigue | 0.96715779 |
| 50 | MP0005253_abnormal_eye_physiology | 0.93343820 |
| 51 | MP0010368_abnormal_lymphatic_system | 0.92367950 |
| 52 | MP0005187_abnormal_penis_morphology | 0.92215365 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 0.90303050 |
| 54 | MP0008877_abnormal_DNA_methylation | 0.88680748 |
| 55 | MP0005670_abnormal_white_adipose | 0.88379066 |
| 56 | MP0008469_abnormal_protein_level | 0.88310391 |
| 57 | MP0009642_abnormal_blood_homeostasis | 0.86633234 |
| 58 | MP0001968_abnormal_touch/_nociception | 0.86603597 |
| 59 | MP0005408_hypopigmentation | 0.84221458 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.82955572 |
| 61 | MP0002272_abnormal_nervous_system | 0.81861447 |
| 62 | MP0002736_abnormal_nociception_after | 0.81491267 |
| 63 | MP0005376_homeostasis/metabolism_phenot | 0.80160657 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.80104466 |
| 65 | MP0002282_abnormal_trachea_morphology | 0.79688968 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.77015584 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.76640635 |
| 68 | MP0001919_abnormal_reproductive_system | 0.75533666 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.75013304 |
| 70 | MP0004133_heterotaxia | 0.74695445 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.74426688 |
| 72 | MP0001485_abnormal_pinna_reflex | 0.73986615 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.73125933 |
| 74 | MP0002971_abnormal_brown_adipose | 0.73042517 |
| 75 | MP0001501_abnormal_sleep_pattern | 0.72706372 |
| 76 | MP0005379_endocrine/exocrine_gland_phen | 0.72577510 |
| 77 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72289318 |
| 78 | MP0003690_abnormal_glial_cell | 0.70342215 |
| 79 | MP0004130_abnormal_muscle_cell | 0.69931537 |
| 80 | MP0005334_abnormal_fat_pad | 0.69157195 |
| 81 | MP0001661_extended_life_span | 0.68932075 |
| 82 | MP0009046_muscle_twitch | 0.67890596 |
| 83 | MP0002064_seizures | 0.67628707 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.66925984 |
| 85 | MP0002938_white_spotting | 0.66922935 |
| 86 | MP0005535_abnormal_body_temperature | 0.66868049 |
| 87 | MP0001324_abnormal_eye_pigmentation | 0.66631027 |
| 88 | MP0005266_abnormal_metabolism | 0.66139894 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 0.66011651 |
| 90 | MP0003878_abnormal_ear_physiology | 0.66011651 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.65641134 |
| 92 | MP0005389_reproductive_system_phenotype | 0.65490961 |
| 93 | MP0009053_abnormal_anal_canal | 0.65018464 |
| 94 | MP0001486_abnormal_startle_reflex | 0.64761326 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.64491959 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.63226775 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.60941065 |
| 98 | * MP0005195_abnormal_posterior_eye | 0.60627583 |
| 99 | MP0003329_amyloid_beta_deposits | 0.60352240 |
| 100 | MP0002132_abnormal_respiratory_system | 0.60279522 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.59249344 |
| 102 | MP0004924_abnormal_behavior | 0.59249344 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 0.58789627 |
| 104 | MP0002160_abnormal_reproductive_system | 0.58678229 |
| 105 | MP0001756_abnormal_urination | 0.57545984 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.57540401 |
| 107 | MP0001984_abnormal_olfaction | 0.56799669 |
| 108 | MP0004742_abnormal_vestibular_system | 0.56720494 |
| 109 | MP0004147_increased_porphyrin_level | 0.55679976 |
| 110 | MP0002735_abnormal_chemical_nociception | 0.54816729 |
| 111 | MP0005448_abnormal_energy_balance | 0.54503257 |
| 112 | MP0003880_abnormal_central_pattern | 0.54192623 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.54047018 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.53054159 |
| 115 | MP0001440_abnormal_grooming_behavior | 0.51750556 |
| 116 | MP0005395_other_phenotype | 0.48988440 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.47905551 |
| 118 | MP0003718_maternal_effect | 0.47732855 |
| 119 | MP0002928_abnormal_bile_duct | 0.46884632 |
| 120 | MP0008873_increased_physiological_sensi | 0.46720261 |
| 121 | MP0008874_decreased_physiological_sensi | 0.46505837 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.44381254 |
| 123 | MP0002822_catalepsy | 0.43527705 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.42761699 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.42244191 |
| 126 | MP0003436_decreased_susceptibility_to | 0.40472578 |
| 127 | MP0003075_altered_response_to | 0.40121288 |
| 128 | MP0003953_abnormal_hormone_level | 0.40062074 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.39846452 |
| 130 | MP0003724_increased_susceptibility_to | 0.39688656 |
| 131 | MP0008872_abnormal_physiological_respon | 0.39559171 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.38614076 |
| 133 | MP0009672_abnormal_birth_weight | 0.37800064 |
| 134 | MP0005166_decreased_susceptibility_to | 0.36294236 |
| 135 | MP0004381_abnormal_hair_follicle | 0.34970485 |
| 136 | MP0000579_abnormal_nail_morphology | 0.34443838 |
| 137 | MP0009115_abnormal_fat_cell | 0.33923764 |
| 138 | MP0001853_heart_inflammation | 0.32826725 |
| 139 | MP0001881_abnormal_mammary_gland | 0.32768052 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.32202654 |
| 141 | MP0002796_impaired_skin_barrier | 0.31991843 |
| 142 | MP0000249_abnormal_blood_vessel | 0.31706802 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.31454755 |
| 144 | MP0001243_abnormal_dermal_layer | 0.31040945 |
| 145 | MP0002970_abnormal_white_adipose | 0.30724448 |
| 146 | MP0004883_abnormal_blood_vessel | 0.30361423 |
| 147 | MP0002168_other_aberrant_phenotype | 0.30151177 |
| 148 | MP0006082_CNS_inflammation | 0.28799152 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.27412662 |
| 150 | MP0002060_abnormal_skin_morphology | 0.24496164 |
| 151 | MP0002090_abnormal_vision | 0.24245982 |
| 152 | MP0005164_abnormal_response_to | 0.24120528 |
| 153 | MP0000427_abnormal_hair_cycle | 0.24062779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.54680321 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.52391590 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.44569987 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.86443165 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.67535879 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.64557557 |
| 7 | * Xanthomatosis (HP:0000991) | 5.96008899 |
| 8 | Complement deficiency (HP:0004431) | 5.36635548 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.93429632 |
| 10 | Joint hemorrhage (HP:0005261) | 4.82961549 |
| 11 | * Hyperlipoproteinemia (HP:0010980) | 4.79856652 |
| 12 | Hyperammonemia (HP:0001987) | 4.73467487 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54229886 |
| 14 | Hyperglycinemia (HP:0002154) | 4.47818861 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.45528334 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.35617771 |
| 17 | Ketosis (HP:0001946) | 4.30769806 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27795658 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.25613591 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.21807298 |
| 21 | Fat malabsorption (HP:0002630) | 4.21521288 |
| 22 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14328034 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.98921936 |
| 24 | Hyperglycinuria (HP:0003108) | 3.96856695 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.96435734 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96435734 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.91315445 |
| 28 | Abnormality of complement system (HP:0005339) | 3.90754350 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81599108 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80443651 |
| 31 | * Epidermoid cyst (HP:0200040) | 3.73954518 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42983825 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.40092274 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38576727 |
| 35 | * Hypercholesterolemia (HP:0003124) | 3.20769710 |
| 36 | Steatorrhea (HP:0002570) | 3.17143986 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.16554285 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.15752044 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13154020 |
| 40 | Congenital stationary night blindness (HP:0007642) | 3.10117998 |
| 41 | Spontaneous abortion (HP:0005268) | 3.09648142 |
| 42 | Ketoacidosis (HP:0001993) | 3.04811706 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.02450104 |
| 44 | Fair hair (HP:0002286) | 3.00039568 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.97446905 |
| 46 | Myocardial infarction (HP:0001658) | 2.91906799 |
| 47 | Metabolic acidosis (HP:0001942) | 2.79336534 |
| 48 | Pancreatic cysts (HP:0001737) | 2.70961423 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.70270062 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.68369018 |
| 51 | Acanthocytosis (HP:0001927) | 2.66065603 |
| 52 | Lethargy (HP:0001254) | 2.65777205 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61077845 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.61077845 |
| 55 | Vascular calcification (HP:0004934) | 2.59046767 |
| 56 | Spastic diplegia (HP:0001264) | 2.57463534 |
| 57 | Abnormality of alanine metabolism (HP:0010916) | 2.57009242 |
| 58 | Hyperalaninemia (HP:0003348) | 2.57009242 |
| 59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.57009242 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.50777310 |
| 61 | Glomerulonephritis (HP:0000099) | 2.49608996 |
| 62 | Cerebral edema (HP:0002181) | 2.48390018 |
| 63 | Abnormality of urine glucose concentration (HP:0011016) | 2.48353463 |
| 64 | Glycosuria (HP:0003076) | 2.48353463 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.47366818 |
| 66 | Gout (HP:0001997) | 2.46365774 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.43122345 |
| 68 | Cholelithiasis (HP:0001081) | 2.40979672 |
| 69 | Bile duct proliferation (HP:0001408) | 2.40287492 |
| 70 | Abnormal biliary tract physiology (HP:0012439) | 2.40287492 |
| 71 | Irritability (HP:0000737) | 2.40064450 |
| 72 | Arthropathy (HP:0003040) | 2.39206839 |
| 73 | Cholecystitis (HP:0001082) | 2.38999791 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.38999791 |
| 75 | True hermaphroditism (HP:0010459) | 2.38725142 |
| 76 | Neonatal onset (HP:0003623) | 2.36801836 |
| 77 | Mitral stenosis (HP:0001718) | 2.36621386 |
| 78 | Molar tooth sign on MRI (HP:0002419) | 2.34046901 |
| 79 | Abnormality of midbrain morphology (HP:0002418) | 2.34046901 |
| 80 | Generalized hypopigmentation of hair (HP:0011358) | 2.32873687 |
| 81 | Pancreatic fibrosis (HP:0100732) | 2.31537086 |
| 82 | Amyloidosis (HP:0011034) | 2.29398324 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.29324046 |
| 84 | Malnutrition (HP:0004395) | 2.29022478 |
| 85 | Pendular nystagmus (HP:0012043) | 2.28839066 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26931873 |
| 87 | Chronic hepatic failure (HP:0100626) | 2.26208282 |
| 88 | Esophageal varix (HP:0002040) | 2.23984949 |
| 89 | Gingival bleeding (HP:0000225) | 2.23576096 |
| 90 | Hyperphosphaturia (HP:0003109) | 2.17918858 |
| 91 | Brushfield spots (HP:0001088) | 2.17071384 |
| 92 | * Skin nodule (HP:0200036) | 2.17057978 |
| 93 | Pancreatitis (HP:0001733) | 2.15740532 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.15249387 |
| 95 | Menorrhagia (HP:0000132) | 2.14670212 |
| 96 | Late onset (HP:0003584) | 2.13312932 |
| 97 | Thrombophlebitis (HP:0004418) | 2.10996427 |
| 98 | Enlarged kidneys (HP:0000105) | 2.10900760 |
| 99 | Nephronophthisis (HP:0000090) | 2.10040428 |
| 100 | Vomiting (HP:0002013) | 2.08342936 |
| 101 | Poikilocytosis (HP:0004447) | 2.04602617 |
| 102 | Generalized aminoaciduria (HP:0002909) | 2.04536351 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03700114 |
| 104 | Opisthotonus (HP:0002179) | 2.03591751 |
| 105 | Decreased central vision (HP:0007663) | 2.03062979 |
| 106 | Hypothermia (HP:0002045) | 2.02671843 |
| 107 | Osteomalacia (HP:0002749) | 2.00571094 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 2.00201937 |
| 109 | Hemorrhage of the eye (HP:0011885) | 1.98654641 |
| 110 | Rickets (HP:0002748) | 1.94333812 |
| 111 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93749275 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.92219233 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.91051469 |
| 114 | Renal cortical cysts (HP:0000803) | 1.90235120 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89560484 |
| 116 | Alkalosis (HP:0001948) | 1.87880599 |
| 117 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87869283 |
| 118 | Abnormality of the renal medulla (HP:0100957) | 1.85527680 |
| 119 | Status epilepticus (HP:0002133) | 1.84889650 |
| 120 | Elevated hepatic transaminases (HP:0002910) | 1.84301976 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.84035373 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.84035373 |
| 123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82098615 |
| 124 | Methylmalonic acidemia (HP:0002912) | 1.81524791 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 1.80254377 |
| 126 | Acute encephalopathy (HP:0006846) | 1.80141155 |
| 127 | Attenuation of retinal blood vessels (HP:0007843) | 1.80004561 |
| 128 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.78614995 |
| 129 | Increased corneal curvature (HP:0100692) | 1.78489333 |
| 130 | Keratoconus (HP:0000563) | 1.78489333 |
| 131 | Large for gestational age (HP:0001520) | 1.78161422 |
| 132 | Nephritis (HP:0000123) | 1.76822905 |
| 133 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75424495 |
| 134 | Hyperventilation (HP:0002883) | 1.72735985 |
| 135 | Cerebral palsy (HP:0100021) | 1.72103367 |
| 136 | Hyperglycemia (HP:0003074) | 1.71741694 |
| 137 | Reduced antithrombin III activity (HP:0001976) | 1.71311439 |
| 138 | Proximal tubulopathy (HP:0000114) | 1.69672039 |
| 139 | Blue irides (HP:0000635) | 1.67595295 |
| 140 | * Abnormality of vitamin metabolism (HP:0100508) | 1.65606037 |
| 141 | Pulmonary embolism (HP:0002204) | 1.56776655 |
| 142 | Methylmalonic aciduria (HP:0012120) | 1.56287338 |
| 143 | Cystic liver disease (HP:0006706) | 1.55126604 |
| 144 | Joint swelling (HP:0001386) | 1.53631004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.28034962 |
| 2 | SIK1 | 4.56321965 |
| 3 | FGFR4 | 4.45341065 |
| 4 | ERN1 | 4.23566081 |
| 5 | WNK3 | 3.08580862 |
| 6 | ADRBK2 | 3.00733418 |
| 7 | INSRR | 2.98688646 |
| 8 | TAOK3 | 2.97308539 |
| 9 | ERBB4 | 2.89007285 |
| 10 | ZAK | 2.51262300 |
| 11 | PKN2 | 2.44972773 |
| 12 | BMPR1B | 2.42274919 |
| 13 | MAP2K4 | 2.37103875 |
| 14 | NUAK1 | 2.34881054 |
| 15 | CASK | 2.34398479 |
| 16 | MAP4K2 | 2.25893408 |
| 17 | MST1R | 2.16868286 |
| 18 | FLT3 | 2.08521864 |
| 19 | CAMKK2 | 1.90303181 |
| 20 | TNIK | 1.90259977 |
| 21 | MAPK11 | 1.88222566 |
| 22 | AKT3 | 1.87518637 |
| 23 | PIK3CG | 1.84683168 |
| 24 | MAPK13 | 1.83716024 |
| 25 | LATS1 | 1.81284052 |
| 26 | TRIB3 | 1.80307064 |
| 27 | PNCK | 1.77043156 |
| 28 | WNK4 | 1.69066439 |
| 29 | TXK | 1.68524997 |
| 30 | TYK2 | 1.66148003 |
| 31 | TAF1 | 1.62236427 |
| 32 | FRK | 1.60168046 |
| 33 | FGFR2 | 1.53343779 |
| 34 | ACVR1B | 1.52822365 |
| 35 | ABL2 | 1.50360066 |
| 36 | PTK6 | 1.48319294 |
| 37 | PAK3 | 1.48278323 |
| 38 | DAPK2 | 1.44721789 |
| 39 | NEK9 | 1.44043861 |
| 40 | TLK1 | 1.42949128 |
| 41 | MAP3K4 | 1.42809521 |
| 42 | MARK1 | 1.36293029 |
| 43 | DYRK2 | 1.32895606 |
| 44 | MUSK | 1.31018612 |
| 45 | KDR | 1.30412302 |
| 46 | NTRK3 | 1.25192087 |
| 47 | MAP3K7 | 1.22582358 |
| 48 | PINK1 | 1.21225298 |
| 49 | JAK2 | 1.20975333 |
| 50 | TRIM28 | 1.16768563 |
| 51 | OXSR1 | 1.14834792 |
| 52 | PRKAA2 | 1.14664753 |
| 53 | NLK | 1.14490323 |
| 54 | MAP3K10 | 1.04743415 |
| 55 | MAP2K3 | 1.04080533 |
| 56 | PRKCE | 1.03902418 |
| 57 | GRK6 | 1.03757984 |
| 58 | MAPK4 | 1.02355884 |
| 59 | TBK1 | 1.01138973 |
| 60 | ERBB2 | 1.00067247 |
| 61 | JAK1 | 0.96387162 |
| 62 | MAP3K14 | 0.94786297 |
| 63 | NEK2 | 0.93406095 |
| 64 | PRKCZ | 0.91329209 |
| 65 | WEE1 | 0.90185136 |
| 66 | STK38L | 0.87573062 |
| 67 | MET | 0.87011245 |
| 68 | CDK6 | 0.86143266 |
| 69 | ADRBK1 | 0.86061718 |
| 70 | MAP3K3 | 0.83719950 |
| 71 | STK39 | 0.81236477 |
| 72 | LIMK1 | 0.80841459 |
| 73 | FER | 0.80569226 |
| 74 | CAMK1D | 0.80449709 |
| 75 | MAPK12 | 0.80093285 |
| 76 | BRSK2 | 0.79880987 |
| 77 | MARK3 | 0.79661972 |
| 78 | EPHB1 | 0.78336689 |
| 79 | TIE1 | 0.76453520 |
| 80 | EPHA3 | 0.76299573 |
| 81 | PRKACG | 0.75677638 |
| 82 | BCR | 0.75208726 |
| 83 | IRAK4 | 0.74780140 |
| 84 | CCNB1 | 0.73756287 |
| 85 | ERBB3 | 0.73697505 |
| 86 | MKNK2 | 0.73113645 |
| 87 | PRKACA | 0.72834636 |
| 88 | MAP3K11 | 0.72100456 |
| 89 | MAPK15 | 0.70061851 |
| 90 | MAP2K6 | 0.68702590 |
| 91 | CAMK2G | 0.68124935 |
| 92 | RIPK1 | 0.66240214 |
| 93 | SGK3 | 0.66178171 |
| 94 | DYRK1B | 0.66149096 |
| 95 | CSK | 0.66012138 |
| 96 | FGFR3 | 0.65530622 |
| 97 | GSK3A | 0.65169467 |
| 98 | PLK2 | 0.65151615 |
| 99 | PRKAA1 | 0.64797417 |
| 100 | TGFBR2 | 0.63321409 |
| 101 | CSF1R | 0.62707718 |
| 102 | PRKCI | 0.61826952 |
| 103 | CAMK2A | 0.60720852 |
| 104 | MAP2K7 | 0.59790134 |
| 105 | IRAK3 | 0.59123549 |
| 106 | MAPK7 | 0.59086987 |
| 107 | GRK7 | 0.57884364 |
| 108 | TNK2 | 0.54614740 |
| 109 | PRKG1 | 0.53397103 |
| 110 | MAPKAPK3 | 0.51415308 |
| 111 | PRKCQ | 0.50395791 |
| 112 | PTK2 | 0.50256202 |
| 113 | SGK2 | 0.49971129 |
| 114 | VRK1 | 0.49666693 |
| 115 | EPHA4 | 0.49257990 |
| 116 | CSNK1G1 | 0.49060540 |
| 117 | IKBKE | 0.48189180 |
| 118 | PDPK1 | 0.48016989 |
| 119 | CAMK1 | 0.47710024 |
| 120 | MAPKAPK5 | 0.47167220 |
| 121 | IGF1R | 0.46824791 |
| 122 | MAP3K5 | 0.46790182 |
| 123 | STK11 | 0.46533329 |
| 124 | TAOK2 | 0.46339262 |
| 125 | GRK1 | 0.45158977 |
| 126 | RET | 0.44787564 |
| 127 | GRK5 | 0.44386801 |
| 128 | CDK4 | 0.42815596 |
| 129 | CSNK1D | 0.42783690 |
| 130 | RPS6KA5 | 0.41547329 |
| 131 | MAP3K6 | 0.40572173 |
| 132 | CSNK1A1 | 0.40467008 |
| 133 | PHKG2 | 0.39873230 |
| 134 | PHKG1 | 0.39873230 |
| 135 | MAP2K1 | 0.39853026 |
| 136 | CSNK1E | 0.39833906 |
| 137 | DYRK1A | 0.38825931 |
| 138 | PDK3 | 0.38575668 |
| 139 | PDK4 | 0.38575668 |
| 140 | PRKCG | 0.37904147 |
| 141 | MAP3K13 | 0.36893377 |
| 142 | TGFBR1 | 0.35117410 |
| 143 | PBK | 0.34872791 |
| 144 | MTOR | 0.34214037 |
| 145 | CAMK2B | 0.34135142 |
| 146 | EGFR | 0.33370593 |
| 147 | SGK494 | 0.32756860 |
| 148 | SGK223 | 0.32756860 |
| 149 | ICK | 0.32657335 |
| 150 | PDK1 | 0.32416047 |
| 151 | IRAK1 | 0.29863478 |
| 152 | CAMK4 | 0.29428442 |
| 153 | PKN1 | 0.29051651 |
| 154 | LATS2 | 0.29043473 |
| 155 | CSNK1G2 | 0.27723504 |
| 156 | IRAK2 | 0.27636246 |
| 157 | CAMK1G | 0.27009879 |
| 158 | PRKCA | 0.25211504 |
| 159 | PIK3CA | 0.24143017 |
| 160 | CSNK1G3 | 0.23649300 |
| 161 | ABL1 | 0.23368511 |
| 162 | MAP3K1 | 0.21015132 |
| 163 | BMX | 0.19212241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49504220 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77999941 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42101178 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38607966 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.10211945 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72886209 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72312380 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67388753 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58793224 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53325824 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49281559 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37559893 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26159873 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14344537 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12615374 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07475053 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95751600 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94605776 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93799931 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93633990 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87462673 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86781721 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82158245 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81193187 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78912079 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78090614 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72682028 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71609729 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70558963 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68055833 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58109670 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56346648 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56172940 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51536859 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49347429 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48623217 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41495255 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35851989 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35473173 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32692022 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31355358 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27801307 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22841377 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19380825 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.18756429 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16678840 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15134298 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13411423 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02474131 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97208800 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96633259 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95464688 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95162812 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90492123 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90184682 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86817189 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86680785 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84787970 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81155117 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75521933 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.75447949 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69985076 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67690978 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64931332 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59151650 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58772887 |
| 67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54175865 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51785803 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49211477 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45844606 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45346251 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44991313 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36690452 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34593605 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34317487 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33588865 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.31615282 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26427564 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.26373545 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25340349 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24786027 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23034714 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22705467 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.22330540 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22166899 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.21343242 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17288308 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15085638 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.12555542 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.12491981 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.11857162 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.11317793 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.10730148 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09610666 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.07307928 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.06360860 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.05281610 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.04701695 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.04663220 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02764768 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.02201249 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01909159 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2537770 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | -0.2505568 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2423106 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2377501 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2225863 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2012704 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2000938 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1922556 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1869727 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | -0.1867943 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1681927 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1640363 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1531940 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1520743 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1519745 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1444115 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1073208 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0994116 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0794395 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0750085 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0598029 |

